Cantor Fitzgerald initiated coverage of Nice (NICE) with a Neutral rating and $176 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze ...
For exclusive news and updates, subscribe to our Survivor Newsletter: It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted ...
COVID-19 put a swift halt to the trend, but as the 100 year anniversary of F. Scott Fitzgerald publishing “The Great Gatsby” approaches, we’ll be seeing some “Jazz Age” stylings around the Twin Cities ...
It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted by comments that the $1 million victory was undeserving. However ...
It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted by comments that the $1 million victory was undeserving. However, years later, ...
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price target of $76.00. The company’s shares ...
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look at where Varonis Systems, Inc. (NASDAQ:VRNS) stands against the ...